Agile Therapeutics Inc (AGRX)
Agile Therapeutics is a women's healthcare company. Co.'s primary product candidate, Twirla, is a once-weekly prescription combination hormonal contraceptive patch. It delivers a dose of estrogen that is consistent with commonly prescribed combined hormonal contraceptives. Co.'s pipeline consists of two classes of product candidates: Co.'s potential product pipeline consists of two types of product candidates: a progestin-only contraceptive patch and potential Twirla line extensions. These potential product candidates are designed to address market needs and provide additional non-daily contraceptive options. Including AG200-15 Extended Regimen, AG200-SmP, and AG200-15 ER SmP.
Company Name: |
Agile Therapeutics Inc |
Website: |
www.agiletherapeutics.com |
Sector: |
Drugs & Pharmaceuticals |
Number of ETFs Holding AGRX: |
1 |
Total Market Value Held by ETFs: |
$6645 |
Total Market Capitalization: |
$2.00M |
% of Market Cap. Held by ETFs: |
0.33% |
|
|
March 29, 2024 4:11 AM Eastern
Strong Buy (4.00 out of 4)
99th percentile
|
|